ISRG vs JNJ
ISRG: Intuitive Surgical is the dominant innovator and market leader in robotic-assisted surgical platforms, driving a shift toward minimally invasive clinical outcomes. JNJ: Johnson & Johnson is a global leader in innovative pharmaceuticals and advanced medical technology dedicated to addressing the world's most complex health challenges.
Side-by-side fundamentals
| Metric | ISRG | JNJ | Edge |
|---|---|---|---|
| Price as of 2026-08-24 close | $373.57 | $273.04 | |
| Market cap as of 2026-08-24 | $132.0B | $658.0B | |
| P/E as of 2026-08-24 | 42.81 | 31.66 | JNJ lower |
| PEG as of 2026-08-24 | 2.42 | 3.39 | ISRG lower |
| Net margin as of 2026-08-24 | +28.4% | +21.5% | ISRG higher |
| Gross margin as of 2026-08-24 | +66.7% | +68.0% | JNJ higher |
| Operating margin as of 2026-08-24 | +31.3% | +25.7% | ISRG higher |
| ROE as of 2026-08-24 | +17.8% | +25.7% | JNJ higher |
| ROA as of 2026-08-24 | +15.5% | +10.6% | ISRG higher |
| Debt / equity as of 2026-08-24 | 0.00 | 0.58 | ISRG lower |
| Revenue growth (YoY) as of 2026-08-24 | +20.7% | +8.1% | ISRG higher |
| Revenue CAGR (3y) SEC XBRL | +17.4% | +6.2% | ISRG higher |
| Dividend yield as of 2026-08-24 | n/a | +3.1% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-24 | 1.16 | -0.02 | |
| 1-year return as of 2026-08-24 close | -21.5% | +52.3% | JNJ higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.